1. Home
  2. CELU vs CIGL Comparison

CELU vs CIGL Comparison

Compare CELU & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.07

Market Cap

50.7M

Sector

Health Care

ML Signal

HOLD

CIGL

Concorde International Group Ltd Class A Ordinary Shares

HOLD

Current Price

$1.57

Market Cap

59.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CELU
CIGL
Founded
2016
1997
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
50.7M
59.4M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
CELU
CIGL
Price
$1.07
$1.57
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
88.8K
21.1K
Earning Date
11-14-2025
09-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,578,000.00
$11,072,733.00
Revenue This Year
N/A
N/A
Revenue Next Year
$76.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.32
52 Week Low
$1.00
$1.40
52 Week High
$4.35
$31.06

Technical Indicators

Market Signals
Indicator
CELU
CIGL
Relative Strength Index (RSI) 27.99 38.56
Support Level $1.25 $1.55
Resistance Level $1.37 $1.94
Average True Range (ATR) 0.15 0.20
MACD -0.03 -0.01
Stochastic Oscillator 9.88 9.07

Price Performance

Historical Comparison
CELU
CIGL

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

Share on Social Networks: